Correlation Between Neurobo Pharmaceuticals and Fortress Biotech
Can any of the company-specific risk be diversified away by investing in both Neurobo Pharmaceuticals and Fortress Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurobo Pharmaceuticals and Fortress Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurobo Pharmaceuticals and Fortress Biotech, you can compare the effects of market volatilities on Neurobo Pharmaceuticals and Fortress Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurobo Pharmaceuticals with a short position of Fortress Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurobo Pharmaceuticals and Fortress Biotech.
Diversification Opportunities for Neurobo Pharmaceuticals and Fortress Biotech
-0.03 | Correlation Coefficient |
Good diversification
The 3 months correlation between Neurobo and Fortress is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Neurobo Pharmaceuticals and Fortress Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fortress Biotech and Neurobo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurobo Pharmaceuticals are associated (or correlated) with Fortress Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fortress Biotech has no effect on the direction of Neurobo Pharmaceuticals i.e., Neurobo Pharmaceuticals and Fortress Biotech go up and down completely randomly.
Pair Corralation between Neurobo Pharmaceuticals and Fortress Biotech
Given the investment horizon of 90 days Neurobo Pharmaceuticals is expected to generate 0.93 times more return on investment than Fortress Biotech. However, Neurobo Pharmaceuticals is 1.07 times less risky than Fortress Biotech. It trades about -0.01 of its potential returns per unit of risk. Fortress Biotech is currently generating about -0.03 per unit of risk. If you would invest 552.00 in Neurobo Pharmaceuticals on December 5, 2024 and sell it today you would lose (363.00) from holding Neurobo Pharmaceuticals or give up 65.76% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.34% |
| Values | Daily Returns |
Neurobo Pharmaceuticals vs. Fortress Biotech
Performance |
| Timeline |
| Neurobo Pharmaceuticals |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
| Fortress Biotech |
Neurobo Pharmaceuticals and Fortress Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neurobo Pharmaceuticals and Fortress Biotech
The main advantage of trading using opposite Neurobo Pharmaceuticals and Fortress Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurobo Pharmaceuticals position performs unexpectedly, Fortress Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fortress Biotech will offset losses from the drop in Fortress Biotech's long position.| Neurobo Pharmaceuticals vs. Allarity Therapeutics | ||
| Neurobo Pharmaceuticals vs. Virax Biolabs Group | ||
| Neurobo Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | ||
| Neurobo Pharmaceuticals vs. Biodexa Pharmaceticals |
| Fortress Biotech vs. Mustang Bio | ||
| Fortress Biotech vs. Achilles Therapeutics PLC | ||
| Fortress Biotech vs. Aptose Biosciences | ||
| Fortress Biotech vs. Fortress Biotech Pref |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |